(VIANEWS) – BanColombia S.A. (CIB), Coastal Financial Corporation (CCB), Casella Waste Systems (CWST) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. BanColombia S.A. (CIB)
57.5% sales growth and 18.11% return on equity
Bancolombia S. A. provides various banking products and services to individual and corporate customers in Colombia, Panama, Puerto Rico, El Salvador, Costa Rica, and Guatemala. The company operates through nine segments: Banking Colombia, Banking Panama, Banking El Salvador, Banking Guatemala, Trust, Investment Banking, Brokerage, International Banking, and All Other. It offers checking and savings accounts, fixed term deposits, and investment products; trade financing, loans funded by domestic development banks, working capital loans, credit cards, personal and vehicle loans, payroll loans, and overdrafts; financial support to real estate developers and mortgages for individuals and companies; and financial and operating leasing services. The company also provides hedging instruments, including futures, forwards, options, and swaps; and brokerage, investment advisory, and private banking services, including selling and distributing equities, futures, foreign currencies, fixed income securities, mutual funds, and structured products. In addition, it offers cash management services; foreign currency transaction services; life, auto, commercial, and homeowner's insurance products; and online and computer banking services. Further, the company provides investment banking services comprising project and acquisition finance, debt and equity capital markets, principal investments, M&A, restructurings, and structured financing; money market accounts, mutual and pension funds, private equity funds, payment trust, custody, and corporate trust; and digital banking platform, transportation, securities brokerage, maintenance and remodeling, advertising and marketing, and outsourcing services, as well as credit cards. As of December 31, 2020, it operated 1,057 branches; 18,631 banking correspondents; 535 PAMs; 215 kiosks in El Salvador and 137 in Colombia; and 6,124 automatic teller machines. Bancolombia S.A. was incorporated in 1945 and is headquartered in MedellÃn, Colombia.
Earnings Per Share
As for profitability, BanColombia S.A. has a trailing twelve months EPS of $6.31.
PE Ratio
BanColombia S.A. has a trailing twelve months price to earnings ratio of 4.05. Meaning, the purchaser of the share is investing $4.05 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 18.11%.
Volume
Today’s last reported volume for BanColombia S.A. is 123763 which is 54.25% below its average volume of 270576.
Revenue Growth
Year-on-year quarterly revenue growth declined by 0.9%, now sitting on 20.68T for the twelve trailing months.
2. Coastal Financial Corporation (CCB)
29.7% sales growth and 18.97% return on equity
Coastal Financial Corporation operates as the bank holding company for Coastal Community Bank that provides various banking products and services to small to medium-sized businesses, professionals, and individuals in the Puget Sound region in Washington. It accepts a range of deposit products, including demand and savings accounts, time deposits, and money market accounts. The company also offers commercial and industrial loans, such as term loans, small business administration loans, commercial lines of credit, capital call lines working capital loans, equipment financing, borrowing base loans, and other loan products; owner-occupied and non-owner-occupied real estate loans, and multi-family residential loans; construction and land development loans; residential real estate loans; and consumer and other loans, including automobile, boat and recreational vehicle, and secured term loans, as well as overdraft protection. In addition, it provides remote deposit capture, online and mobile banking, and direct and reciprocal deposit services, as well as debit cards. Further, the company offers business accounts and cash management services, including business checking and savings accounts, and treasury services, as well as banking as a service, a platform that allows broker dealers and digital financial service providers to offer their customers banking services. Coastal Financial Corporation was founded in 1997 and is headquartered in Everett, Washington.
Earnings Per Share
As for profitability, Coastal Financial Corporation has a trailing twelve months EPS of $3.58.
PE Ratio
Coastal Financial Corporation has a trailing twelve months price to earnings ratio of 10.92. Meaning, the purchaser of the share is investing $10.92 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 18.97%.
Moving Average
Coastal Financial Corporation’s worth is under its 50-day moving average of $42.10 and under its 200-day moving average of $40.46.
Volume
Today’s last reported volume for Coastal Financial Corporation is 40805 which is 8.1% above its average volume of 37747.
Revenue Growth
Year-on-year quarterly revenue growth grew by 6.8%, now sitting on 261M for the twelve trailing months.
3. Casella Waste Systems (CWST)
27.9% sales growth and 4.7% return on equity
Casella Waste Systems, Inc., together with its subsidiaries, operates as a vertically integrated solid waste services company in the northeastern United States. It offers resource management services primarily in the areas of solid waste collection and disposal, transfer, recycling, and organics services to residential, commercial, municipal, and industrial customers. The company provides a range of non-hazardous solid waste services, including collections, transfer stations, and disposal facilities. It also markets recyclable metals, aluminum, plastics, and paper and corrugated cardboard that are processed at its facilities, as well as recyclables purchased from third parties. In addition, the company is involved in commodity brokerage operations. As of April 15, 2021, it owned and/or operated 46 solid waste collection operations, 58 transfer stations, 20 recycling facilities, 8 Subtitle D landfills, 4 landfill gas-to-energy facilities, and 1 landfill permitted to accept construction and demolition materials. The company was founded in 1975 and is headquartered in Rutland, Vermont.
Earnings Per Share
As for profitability, Casella Waste Systems has a trailing twelve months EPS of $0.77.
PE Ratio
Casella Waste Systems has a trailing twelve months price to earnings ratio of 96.84. Meaning, the purchaser of the share is investing $96.84 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.7%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 19.5%, now sitting on 1.18B for the twelve trailing months.
Sales Growth
Casella Waste Systems’s sales growth is 33.6% for the present quarter and 27.9% for the next.
Moving Average
Casella Waste Systems’s value is under its 50-day moving average of $78.39 and under its 200-day moving average of $82.85.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Jan 1, 1970, the estimated forward annual dividend yield is 1.85%.
4. Corcept Therapeutics Incorporated (CORT)
19% sales growth and 21.9% return on equity
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and psychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing's syndrome, who have type 2 diabetes mellitus or glucose intolerance, and have failed surgery or are not candidates for surgery. It is developing relacorilant to treat patients with Cushing's syndrome; and nab-paclitaxel in combination with relacorilant, which has completed Phase II clinical trial to treat patients with serous ovarian tumors, as well as in Phase III clinical trial for the treatment of solid tumors. The company is also developing selective cortisol modulator combined with Xtandi that is in open label dose finding trial to treat patients with metastatic castration-resistant prostate cancer; selective cortisol modulator for the treatment of antipsychotic-induced weight gain; and FKBP5 gene expression assays. Corcept Therapeutics Incorporated was founded in 1998 and is headquartered in Menlo Park, California.
Earnings Per Share
As for profitability, Corcept Therapeutics Incorporated has a trailing twelve months EPS of $0.81.
PE Ratio
Corcept Therapeutics Incorporated has a trailing twelve months price to earnings ratio of 34.68. Meaning, the purchaser of the share is investing $34.68 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 21.9%.
Sales Growth
Corcept Therapeutics Incorporated’s sales growth is 17.6% for the current quarter and 19% for the next.
Revenue Growth
Year-on-year quarterly revenue growth grew by 13.9%, now sitting on 428.15M for the twelve trailing months.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Jan 1, 1970, the estimated forward annual dividend yield is 0.31%.
